Federal Panel Recommends Expanded Vaccines for Adults and Teens
An expert panel recommends expanded RSV vaccinations, a new meningitis shot, and chikungunya vaccine options for travelers, amid uncertainty around decision-making on these recommendations.
Overview
A federal panel has recommended expanding RSV vaccinations for adults, endorsing a new combination meningitis shot for teens, and offering additional chikungunya vaccine options for travelers. This comes as the CDC's leadership remains uncertain, with acting director Susan Monarez awaiting Senate confirmation. Recommendations include vaccinations for people aged 50 to 59 at risk for RSV, and precautions for the chikungunya vaccine for older adults due to reported health issues post-vaccination. The Department of Health and Human Services is reviewing how to implement these recommendations.
Report issue
Read both sides in 5 minutes each day
Analysis
- A federal panel recommended expanding RSV vaccinations for adults and introduced new vaccination options for teens and travelers.
- The decision-making process regarding vaccine recommendations is uncertain due to the acting CDC director's recusal and potential implications from Health Secretary Kennedy, known for his anti-vaccine stance.
- The panel's recommendations include specific age and health considerations for vaccines, especially concerning the risks faced by older populations.
Articles (3)
FAQ
No FAQs available for this story.
History
- This story does not have any previous versions.